Is HD a buy, hold, or sell?
HD carries a valuation grade of Hold. At a trailing P/E of 22.7, the stock trades at a 13% discount to the Consumer Cyclical sector median of 26.0x. Our discounted cash flow model produces an intrinsic range of $286–$421 — implying a +11% margin of safety at the current price of $318.92. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 6% beat rate on recent quarters, earnings predictability has been mixed. Analyst estimate revisions are trending upward.
What are HD's key risk factors?
With a beta of 0.97, HD exhibits a market-neutral risk profile relative to the broad market. The 95th-percentile CVaR of -15.0% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.5% of total portfolio loss in the worst 5% of months. Net margins stand at 8.4%. Return on equity of 128.4% indicates highly efficient capital allocation. Debt-to-equity of 459% warrants monitoring for leverage risk.
Implied volatility of 2.7% is below realized volatility of 24.9%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $42.4M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 1.3% of float, suggesting limited bearish conviction.
How does HD fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — HD carries a beta of 0.97, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, HD shows the strongest co-movement with PG (0.45), MCD (0.40), WMT (0.29). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The HD analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning HD’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
